Anti-Cardiolipin is an indirect solid phase enzyme immunoassay ( ELISA ) for the simultaneous quantitative measurement
of IgG, IgM and IgA class autoantibodies against cardiolipin in human serum or plasma. The assay is intended for in vitro use only as an aid in the determination of an increased risk of thrombosis in patients with Systemic Lupus Erythematosus ( SLE ) or lupus-like disorders.